Lindbrook Capital, LLC Eagle Pharmaceuticals, Inc. Transaction History

Lindbrook Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	SELL	$25.06 - $34.09 $2,380 - $3,238	-95 Reduced 34.3%	182 $5,000
Q4 2022 Jan 24, 2023	BUY	$24.98 - $39.77 $3,946 - $6,283	158 Added 132.77%	277 $0
Q3 2022 Nov 10, 2022	BUY	$26.42 - $47.12 $3,143 - $5,607	119 New	119 $3,000
Q2 2021 Jul 27, 2021	SELL	$36.86 - $44.5 $884 - $1,068	-24 Closed	0 $0
Q1 2020 Apr 22, 2020	BUY	$34.37 - $60.07 $824 - $1,441	24 New	24 $1,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.